Hims (HIMS): FY25 Q1 earnings call, May 5, 2025
No Kalshi or Polymarket word markets were listed for Hims’s May 5, 2025 earnings call (FY25 Q1). The transcript is searchable below (quotes of at most 25 words).
UpdatedTranscript
quotes of at most 25 wordsSpeaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.
6 matches for “Peptide”; 5 quoted, at least 25 words apart.
…in longevity, sleep, and preventative care as we expand lab testing and peptide capabilities. Third, we'll elevate precision care without sacrificing convenience. With nearly 2.4…
…We also received a number of questions on the recently announced acquired peptide and lab testing facilities. This one comes from [Nick G] (ph) who…
…operations and capabilities that can deliver really cutting edge care for patients. Peptide innovation is expanding very, very rapidly. This is something our team is…
…when I think of those types of categories, the innovation happening in peptides is generally innovation that's accessible really to only the extreme wealthy subset…
…population has to the masses at affordable and hyper-personalized scale. So the peptide facility, I think it's going to be a really vital component of…
Agents: this page as TSV at /api/v1/appearances/hims:2025-05-05:earnings_call · words: /api/v1/brief?appearance=hims:2025-05-05:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP